CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) - 3 months ended Oct. 31, 2020 - USD ($)	Preferred Stock Series B Preferred Stock	Preferred Stock	Common Stock	Additional Paid-In Capital	Common Stock Subscription Receivable From Related Party	Accumulated Deficit	Total
Beginning Balance at Jul. 31, 2020	$ 72	$ 202	$ 9,669	$ 1,456,644	$ (550,000)	$ (1,066,928)	$ (150,341)
Beginning Balance (in shares) at Jul. 31, 2020	1,347	1,434	96,691,761
Payments received on common stock subscription receivable from related party					67,400		67,400
Conversion of unsecured convertible promissory note payable			$ 13	25,669			25,682
Conversion of unsecured convertible promissory note payable (in share)			128,410
Sales of common stock			$ 1,320	658,680			660,000
Sales of common stock (in share)			13,200,000
Stock-based compensation expense				22,239			22,239
Net loss						(477,730)	(477,730)
Ending Balance at Oct. 31, 2020	$ 72	$ 202	$ 11,002	$ 2,163,232	$ (482,600)	$ (1,544,658)	$ 147,250
Ending Balance (in shares) at Oct. 31, 2020	1,347	1,434	110,020,171